Linden makes ~4x its money on SeraCare sale

Aurora Diagnostics, Summit Partners, KRG Capital, private equity, merger, M&A
Photo courtesy Motortion/iStock/Getty Images
Linden Capital Partners generated an about 4x return through its sale of SeraCare Life Sciences, according to a source familiar with the matter. KKR said earlier this week it would buy SeraCare, a supplier of biological products to the diagnostics ...

This content is available for Buyouts subscribers only. Request a free trial to get access for a limited period

If you already have an active Buyouts subscription, please sign in to view this article.